FDA.reportPublic FDA data

tafluprost 0.015 MG/ML Ophthalmic Solution

RxCUI
1244611
RxNorm name
tafluprost 0.015 MG/ML Ophthalmic Solution
Display name
tafluprost 0.015 MG/ML Ophthalmic Solution
Full name
tafluprost 0.015 MG/ML Ophthalmic Solution
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:19

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 5 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
TafluprostTAFLUPROSTSandoz Incbfffa484-4105-45ec-ab1d-124e96639f352026-08-15Warnings, Adverse reactionsExact identifier
rxcui: 1244611
ZIOPTANTAFLUPROSTThea Pharma Inc.db529b54-2ac7-4020-9791-7333bbe6c90f2026-04-23Adverse reactionsExact identifier
rxcui: 1244611
tafluprostTAFLUPROST OPTHALMICMicro Labs Limitedfcaab8b3-3791-49ba-909e-a09651a30b332026-03-06Warnings, Adverse reactionsExact identifier
rxcui: 1244611
TafluprostTAFLUPROSTIngenus Pharmaceuticals, LLC5d766054-d13f-462c-bf8a-6462e56ca0972024-12-04Warnings, Adverse reactionsExact identifier
rxcui: 1244611
Tafluprost OphthalmicTAFLUPROSTPrasco Laboratories79fceaef-7d83-4f4b-8d5c-61a6c1ee63682022-06-01Warnings, Adverse reactionsExact identifier
rxcui: 1244611

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 6 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
bfffa484-4105-45ec-ab1d-124e96639f35tafluprost 0.0015 % Ophthalmic Solution [PSN] · tafluprost 0.015 MG/ML Ophthalmic Solution [SCD] · tafluprost 0.0015 % Ophthalmic Solution [SY]312These highlights do not include all the information needed to use TAFLUPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for TAFLUPROST OPHTHALMIC SOLUTION. TAFLUPROST ophthalmic solution 0.0015%, for topical ophthalmic use Initial U.S. Approval: 201220260325
a3173c26-0e19-47af-a01c-3fc06b2700d1tafluprost 0.0015 % Ophthalmic Solution [PSN] · tafluprost 0.015 MG/ML Ophthalmic Solution [SCD] · tafluprost 0.0015 % Ophthalmic Solution [SY]310These highlights do not include all the information needed to use ZIOPTAN ® (tafluprost ophthalmic solution) 0.0015% safely and effectively. See full prescribing information for ZIOPTAN ® . ZIOPTAN ® (tafluprost ophthalmic solution) 0.0015% Initial U.S. Approval: 201220221004
db529b54-2ac7-4020-9791-7333bbe6c90ftafluprost 0.0015 % Ophthalmic Solution [PSN] · tafluprost 0.015 MG/ML Ophthalmic Solution [SCD] · tafluprost 0.0015 % Ophthalmic Solution [SY]37These highlights do not include all the information needed to use ZIOPTAN ® (tafluprost ophthalmic solution) 0.0015% safely and effectively. See full prescribing information for ZIOPTAN ® . ZIOPTAN ® (tafluprost ophthalmic solution) 0.0015% Initial U.S. Approval: 201220260423
5d766054-d13f-462c-bf8a-6462e56ca097tafluprost 0.0015 % Ophthalmic Solution [PSN] · tafluprost 0.015 MG/ML Ophthalmic Solution [SCD] · tafluprost 0.0015 % Ophthalmic Solution [SY]37These highlights do not include all the information needed to use TAFLUPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for TAFLUPROST OPHTHALMIC SOLUTION. TAFLUPROST ophthalmic solution Initial U.S. Approval: 201220241204
fcaab8b3-3791-49ba-909e-a09651a30b33tafluprost 0.0015 % Ophthalmic Solution [PSN] · tafluprost 0.015 MG/ML Ophthalmic Solution [SCD] · tafluprost 0.0015 % Ophthalmic Solution [SY]36These highlights do not include all the information needed to use TAFLUPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for TAFLUPROST OPHTHALMIC SOLUTION. TAFLUPROST ophthalmic solution 0.0015%, for topical ophthalmic use Initial U.S. Approval: 201220260306
79fceaef-7d83-4f4b-8d5c-61a6c1ee6368tafluprost 0.0015 % Ophthalmic Solution [PSN] · tafluprost 0.015 MG/ML Ophthalmic Solution [SCD] · tafluprost 0.0015 % Ophthalmic Solution [SY]31These highlights do not include all the information needed to use Tafluprost Ophthalmic Solution 0.0015% safely and effectively. See full prescribing information for Tafluprost Ophthalmic Solution. Tafluprost Ophthalmic Solution 0.0015% Initial U.S. Approval: 201220220601